About Ology Bio
Ology Bio is a company based in Alachua (United States) founded in 1999 was acquired by Resilience in April 2021. Ology Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others.
- Headquarter Alachua, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$8.4 M (USD), Grant
Aug 01, 2018
-
Investors
NIH
& 8 more
-
Employee Count
Not available
-
Acquired by
Resilience
(Apr 12, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ology Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Ology Bio
Investors in Ology Bio
Ology Bio has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Hercules Capital and US Navy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Locked | Locked | Locked | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked |
Investor details for Ology Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ology Bio
Investment portfolio details for Ology Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ology Bio
Detailed financials for Ology Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ology Bio Comparisons
Peer comparison for Ology Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ology Bio
Ology Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Eurogentec, EirGenix and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of Ology Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ology Bio
Complete news archive for Ology Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ology Bio
Ology Bio was founded in 1999 and raised its 1st funding round 6 years after it was founded.
Ology Bio is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
Peter Khoury is the current CEO of Ology Bio.
Ology Bioservices (formerly Nanotherapeutics) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. It offers services such as process development, cell line development, cGMP manufacturing, analytical regulatory for recombinant proteins, monoclonal antibodies, viral vaccines, and gene therapy drug products. The company has developed proprietary vaccine delivery technologies and platform expression systems. The company uses their proprietary Vero Cell vaccine manufacturing cell line acquired from BaxaltaBaxter Vaccines for the development of inactivated whole virus vaccines. It offers mammalian cell line development capabilities. The company has a BSL-3 cGMP compliant vaccines manufacturing facility called Advanced Development and Manufacturing (ADM) facility. The company has several vaccine programs available for partnering andor licensing such as ross river (phase III), chikungunya, pandemic and seasonal flu vaccines, yellow fever (MVA), typhoid, West Nile and norovirus.
Ology Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.
Ology Bio has 9 investors. Key investors include NIH, Hercules Capital, US Navy, Resilience, and DARPA.